NCT00716144 - Dose Ranging Study of the Safety and Efficacy of R115966 in Plaque Psoriasis | Biotech Hunter

Enrollment

176

Participants

Timeline

Start Date

June 1, 2006

Primary Completion Date

May 1, 2007

Study Completion Date

May 1, 2007

Conditions

Psoriasis

Interventions

DRUG

Talarozole

Oral Capsule Once Daily

Trial Locations (22)

GSK Investigational Site, Augsburg

GSK Investigational Site, Berlin

GSK Investigational Site, Dresden

GSK Investigational Site, Frankfurt

GSK Investigational Site, Hamburg

GSK Investigational Site, Salzwedel

GSK Investigational Site, Cork

GSK Investigational Site, Maastricht

GSK Investigational Site, Nijmegen

GSK Investigational Site, Korolyov

GSK Investigational Site, Lipetsk

GSK Investigational Site, Moscow

GSK Investigational Site, Saint Petersburg

GSK Investigational Site, Smolensk

GSK Investigational Site, Veliky Novgorod

GSK Investigational Site, Yaroslavl

GSK Investigational Site, Aberdeen

GSK Investigational Site, Amersham

GSK Investigational Site, Coventry

GSK Investigational Site, Glasgow

GSK Investigational Site, Manchester

GSK Investigational Site, Norwich